ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 190 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,508,371 | -19.8% | 1,197,472 | +12.6% | 0.02% | -11.8% |
| Q2 2023 | $6,868,143 | +19.5% | 1,063,180 | +39.5% | 0.02% | +6.2% |
| Q1 2023 | $5,748,089 | -40.9% | 762,346 | -20.6% | 0.02% | -48.4% |
| Q4 2022 | $9,732,013 | -18.0% | 960,712 | -20.0% | 0.03% | -22.5% |
| Q3 2022 | $11,873,000 | +53.2% | 1,200,538 | +64.9% | 0.04% | +53.8% |
| Q2 2022 | $7,752,000 | +60.3% | 727,922 | +46.8% | 0.03% | +85.7% |
| Q1 2022 | $4,836,000 | -34.4% | 495,984 | -3.8% | 0.01% | -12.5% |
| Q4 2021 | $7,373,000 | +337.6% | 515,600 | +513.1% | 0.02% | +300.0% |
| Q3 2021 | $1,685,000 | -79.7% | 84,100 | -77.7% | 0.00% | -78.9% |
| Q2 2021 | $8,299,000 | +119.6% | 377,216 | +239.0% | 0.02% | +90.0% |
| Q1 2021 | $3,779,000 | – | 111,285 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |